BGXX Stock Overview
Bright Green Corporation focuses on the cultivation, manufacture, and sale of cannabis and cannabis-related products.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Bright Green Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.22 |
| 52 Week High | US$1.81 |
| 52 Week Low | US$0.15 |
| Beta | 0 |
| 1 Month Change | -21.43% |
| 3 Month Change | -17.56% |
| 1 Year Change | -83.87% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -99.12% |
Recent News & Updates
Shareholder Returns
| BGXX | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | -7.2% | -2.2% | -3.7% |
| 1Y | -83.9% | 11.6% | 20.5% |
Return vs Industry: BGXX underperformed the US Pharmaceuticals industry which returned 11.6% over the past year.
Return vs Market: BGXX underperformed the US Market which returned 20.5% over the past year.
Price Volatility
| BGXX volatility | |
|---|---|
| BGXX Average Weekly Movement | 21.0% |
| Pharmaceuticals Industry Average Movement | 9.6% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: BGXX's share price has been volatile over the past 3 months.
Volatility Over Time: BGXX's weekly volatility has increased from 16% to 21% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2019 | 5 | Groovy Singh | www.brightgreen.us |
Bright Green Corporation focuses on the cultivation, manufacture, and sale of cannabis and cannabis-related products. Its products are used in research, pharmaceutical applications, and affiliated exports. The company was incorporated in 2019 and is based in Grants, New Mexico.
Bright Green Corporation Fundamentals Summary
| BGXX fundamental statistics | |
|---|---|
| Market cap | US$42.33m |
| Earnings (TTM) | -US$13.13m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-3.2x
P/E RatioIs BGXX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BGXX income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$13.13m |
| Earnings | -US$13.13m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.069 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 1.8% |
How did BGXX perform over the long term?
See historical performance and comparison